Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 192

The DOI matches its Crossref record.

The classification of prostaglandin DP‐receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist

Open access
Giles, Heather, Leff, P., Bolofo, Mary L., Kelly, M.G., Robertson, A.D. · 1989 · British Journal of Pharmacology

Abstract

BW A868C, a novel compound, behaved as a simple competitive antagonist in a human washed platelet aggregation assay. Anti‐aggregatory concentration‐effect curves to BW 245C were displaced in a parallel manner. The shifts accorded with a Schild plot slope of unity and a pK B of 9.26. Inhibition of platelet aggregation by prostaglandin D 2 (PGD 2) was antagonized with a similar potency, as were the relaxation effects of BW 245C and PGD 2 in the rabbit jugular vein. BW A868C can, therefore, be classified as a DP‐receptor antagonist. Actions of BW A868C at other prostaglandin receptors (IP, EP1, EP 2, TP and FP) were excluded at concentrations up to 1,000 times higher than the DP‐receptor affinity. Analyses of BW 245C‐ and PGD 2‐mediated effects were complicated by additional agonist receptor interactions which were revealed by BW A868C. In rabbit jugular vein a resistant phase of agonism was detectable, indicating that both agonists exerted effects through another receptor (possibly EP 2). Also, PGD 2, in addition to its anti‐aggregatory effect on platelets, demonstrated a pro‐aggregatory action in the presence of BW A868C. The contractile effects of PGD 2 in guinea‐pig tracheal strips were resistant to 10 μ m BW A868C indicating that they were not mediated through DP‐receptors. To our knowledge this is the first account of a well‐classified competitive antagonist at the DP‐receptor. Its potency and selectivity make it an important new tool in prostanoid receptor classification and identification.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.1989.tb11816.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 192

Metadata

Authors
Giles, H., Leff, P., Bolofo, M. L., Kelly, M. G., & Robertson, A. D.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1989-02
Volume
96
Issue
2
Pages
291-300
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1994424025
Cited by
192
References
0
FWCI
8.64
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The classification of prostaglandin DP‐receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. https://app.cochat.ai/papers/10.1111/j.1476-5381.1989.tb11816.x
The paper
Giles, H., Leff, P., Bolofo, M. L., Kelly, M. G., & Robertson, A. D. (1989). The classification of prostaglandin DP‐receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1989.tb11816.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.